nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SIGMAR1—Progesterone—uterine cancer	0.179	0.251	CbGbCtD
Fluvoxamine—CYP1A1—Progesterone—uterine cancer	0.0635	0.0889	CbGbCtD
Fluvoxamine—CYP3A7—Progesterone—uterine cancer	0.0508	0.0712	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0508	0.0712	CbGbCtD
Fluvoxamine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0386	0.054	CbGbCtD
Fluvoxamine—CYP3A5—Progesterone—uterine cancer	0.0381	0.0534	CbGbCtD
Fluvoxamine—CYP2C19—Progesterone—uterine cancer	0.0307	0.0431	CbGbCtD
Fluvoxamine—CYP1A2—Progesterone—uterine cancer	0.0284	0.0397	CbGbCtD
Fluvoxamine—CYP2C9—Progesterone—uterine cancer	0.0255	0.0358	CbGbCtD
Fluvoxamine—ABCB1—Progesterone—uterine cancer	0.0248	0.0347	CbGbCtD
Fluvoxamine—CYP2D6—Progesterone—uterine cancer	0.0234	0.0327	CbGbCtD
Fluvoxamine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0224	0.0314	CbGbCtD
Fluvoxamine—CYP2E1—Etoposide—uterine cancer	0.0219	0.0307	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—uterine cancer	0.0197	0.0275	CbGbCtD
Fluvoxamine—CYP3A5—Etoposide—uterine cancer	0.017	0.0239	CbGbCtD
Fluvoxamine—CYP3A4—Progesterone—uterine cancer	0.0149	0.0208	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—uterine cancer	0.0148	0.0207	CbGbCtD
Fluvoxamine—CYP1A2—Etoposide—uterine cancer	0.0127	0.0178	CbGbCtD
Fluvoxamine—ABCB1—Etoposide—uterine cancer	0.0111	0.0155	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—uterine cancer	0.00757	0.0106	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—uterine cancer	0.00713	0.00999	CbGbCtD
Fluvoxamine—CYP3A4—Etoposide—uterine cancer	0.00665	0.00931	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—uterine cancer	0.00453	0.00635	CbGbCtD
Fluvoxamine—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00241	1	CbGdCrCtD
Fluvoxamine—SIGMAR1—myometrium—uterine cancer	0.000465	0.049	CbGeAlD
Fluvoxamine—SIGMAR1—uterine cervix—uterine cancer	0.000362	0.0381	CbGeAlD
Fluvoxamine—SIGMAR1—smooth muscle tissue—uterine cancer	0.000352	0.037	CbGeAlD
Fluvoxamine—SIGMAR1—decidua—uterine cancer	0.000345	0.0363	CbGeAlD
Fluvoxamine—SIGMAR1—endometrium—uterine cancer	0.000327	0.0345	CbGeAlD
Fluvoxamine—SIGMAR1—mammalian vulva—uterine cancer	0.000317	0.0334	CbGeAlD
Fluvoxamine—SIGMAR1—uterus—uterine cancer	0.000302	0.0318	CbGeAlD
Fluvoxamine—SLC6A4—female reproductive system—uterine cancer	0.000273	0.0288	CbGeAlD
Fluvoxamine—SIGMAR1—female gonad—uterine cancer	0.000247	0.026	CbGeAlD
Fluvoxamine—CYP1A1—epithelium—uterine cancer	0.000245	0.0258	CbGeAlD
Fluvoxamine—SIGMAR1—vagina—uterine cancer	0.000245	0.0258	CbGeAlD
Fluvoxamine—CYP1A1—uterine cervix—uterine cancer	0.000243	0.0256	CbGeAlD
Fluvoxamine—CYP3A5—uterine cervix—uterine cancer	0.000238	0.0251	CbGeAlD
Fluvoxamine—CYP1A2—renal system—uterine cancer	0.000231	0.0243	CbGeAlD
Fluvoxamine—CYP1A1—renal system—uterine cancer	0.000228	0.024	CbGeAlD
Fluvoxamine—CYP3A5—renal system—uterine cancer	0.000223	0.0234	CbGeAlD
Fluvoxamine—CYP2B6—renal system—uterine cancer	0.000221	0.0233	CbGeAlD
Fluvoxamine—CYP1A1—mammalian vulva—uterine cancer	0.000213	0.0224	CbGeAlD
Fluvoxamine—CYP2E1—renal system—uterine cancer	0.000208	0.0219	CbGeAlD
Fluvoxamine—CYP2C19—vagina—uterine cancer	0.000205	0.0216	CbGeAlD
Fluvoxamine—CYP1A1—uterus—uterine cancer	0.000203	0.0214	CbGeAlD
Fluvoxamine—CYP1A1—female reproductive system—uterine cancer	0.000182	0.0192	CbGeAlD
Fluvoxamine—CYP2B6—female reproductive system—uterine cancer	0.000177	0.0187	CbGeAlD
Fluvoxamine—CYP2C9—female reproductive system—uterine cancer	0.000175	0.0185	CbGeAlD
Fluvoxamine—CYP3A4—renal system—uterine cancer	0.000167	0.0176	CbGeAlD
Fluvoxamine—CYP2E1—female reproductive system—uterine cancer	0.000166	0.0175	CbGeAlD
Fluvoxamine—CYP1A1—female gonad—uterine cancer	0.000166	0.0175	CbGeAlD
Fluvoxamine—CYP1A1—vagina—uterine cancer	0.000165	0.0174	CbGeAlD
Fluvoxamine—CYP2D6—renal system—uterine cancer	0.000164	0.0173	CbGeAlD
Fluvoxamine—ABCB1—myometrium—uterine cancer	0.000162	0.0171	CbGeAlD
Fluvoxamine—CYP3A5—female gonad—uterine cancer	0.000162	0.0171	CbGeAlD
Fluvoxamine—CYP3A5—vagina—uterine cancer	0.000161	0.017	CbGeAlD
Fluvoxamine—CYP2B6—vagina—uterine cancer	0.00016	0.0169	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—uterine cancer	0.000159	0.0167	CbGeAlD
Fluvoxamine—CYP3A4—female reproductive system—uterine cancer	0.000134	0.0141	CbGeAlD
Fluvoxamine—CYP2D6—female reproductive system—uterine cancer	0.000132	0.0139	CbGeAlD
Fluvoxamine—ABCB1—epithelium—uterine cancer	0.000127	0.0134	CbGeAlD
Fluvoxamine—ABCB1—uterine cervix—uterine cancer	0.000126	0.0133	CbGeAlD
Fluvoxamine—ABCB1—decidua—uterine cancer	0.00012	0.0127	CbGeAlD
Fluvoxamine—CYP2D6—female gonad—uterine cancer	0.00012	0.0126	CbGeAlD
Fluvoxamine—ABCB1—renal system—uterine cancer	0.000118	0.0125	CbGeAlD
Fluvoxamine—ABCB1—endometrium—uterine cancer	0.000114	0.012	CbGeAlD
Fluvoxamine—ABCB1—mammalian vulva—uterine cancer	0.000111	0.0116	CbGeAlD
Fluvoxamine—CYP1A1—lymph node—uterine cancer	0.000107	0.0112	CbGeAlD
Fluvoxamine—ABCB1—uterus—uterine cancer	0.000105	0.0111	CbGeAlD
Fluvoxamine—Anorexia—Etoposide—uterine cancer	0.000105	0.000416	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000105	0.000415	CcSEcCtD
Fluvoxamine—Bronchitis—Epirubicin—uterine cancer	0.000105	0.000414	CcSEcCtD
Fluvoxamine—Diarrhoea—Dactinomycin—uterine cancer	0.000104	0.000413	CcSEcCtD
Fluvoxamine—Hypotension—Etoposide—uterine cancer	0.000103	0.000408	CcSEcCtD
Fluvoxamine—Gastritis—Doxorubicin—uterine cancer	0.000103	0.000408	CcSEcCtD
Fluvoxamine—Muscular weakness—Doxorubicin—uterine cancer	0.000103	0.000407	CcSEcCtD
Fluvoxamine—Dysuria—Epirubicin—uterine cancer	0.000102	0.000403	CcSEcCtD
Fluvoxamine—Abdominal distension—Doxorubicin—uterine cancer	0.000101	0.000401	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000101	0.0004	CcSEcCtD
Fluvoxamine—Influenza—Doxorubicin—uterine cancer	0.000101	0.000399	CcSEcCtD
Fluvoxamine—Asthma—Doxorubicin—uterine cancer	0.000101	0.000399	CcSEcCtD
Fluvoxamine—Dysphagia—Doxorubicin—uterine cancer	0.000101	0.000399	CcSEcCtD
Fluvoxamine—Pollakiuria—Epirubicin—uterine cancer	0.0001	0.000398	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Epirubicin—uterine cancer	9.93e-05	0.000393	CcSEcCtD
Fluvoxamine—Paraesthesia—Etoposide—uterine cancer	9.91e-05	0.000392	CcSEcCtD
Fluvoxamine—Weight increased—Epirubicin—uterine cancer	9.9e-05	0.000392	CcSEcCtD
Fluvoxamine—Pancreatitis—Doxorubicin—uterine cancer	9.87e-05	0.000391	CcSEcCtD
Fluvoxamine—Weight decreased—Epirubicin—uterine cancer	9.84e-05	0.00039	CcSEcCtD
Fluvoxamine—Dyspnoea—Etoposide—uterine cancer	9.84e-05	0.00039	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Epirubicin—uterine cancer	9.81e-05	0.000389	CcSEcCtD
Fluvoxamine—Somnolence—Etoposide—uterine cancer	9.81e-05	0.000388	CcSEcCtD
Fluvoxamine—Angina pectoris—Doxorubicin—uterine cancer	9.8e-05	0.000388	CcSEcCtD
Fluvoxamine—Pneumonia—Epirubicin—uterine cancer	9.76e-05	0.000386	CcSEcCtD
Fluvoxamine—Drowsiness—Epirubicin—uterine cancer	9.7e-05	0.000384	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—uterine cancer	9.69e-05	0.000384	CcSEcCtD
Fluvoxamine—Bronchitis—Doxorubicin—uterine cancer	9.68e-05	0.000383	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	9.62e-05	0.000381	CcSEcCtD
Fluvoxamine—Rash—Dactinomycin—uterine cancer	9.61e-05	0.000381	CcSEcCtD
Fluvoxamine—Decreased appetite—Etoposide—uterine cancer	9.59e-05	0.00038	CcSEcCtD
Fluvoxamine—Renal failure—Epirubicin—uterine cancer	9.53e-05	0.000377	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Etoposide—uterine cancer	9.53e-05	0.000377	CcSEcCtD
Fluvoxamine—Fatigue—Etoposide—uterine cancer	9.51e-05	0.000377	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Epirubicin—uterine cancer	9.51e-05	0.000376	CcSEcCtD
Fluvoxamine—ABCB1—female reproductive system—uterine cancer	9.47e-05	0.00997	CbGeAlD
Fluvoxamine—Jaundice—Epirubicin—uterine cancer	9.45e-05	0.000374	CcSEcCtD
Fluvoxamine—Stomatitis—Epirubicin—uterine cancer	9.45e-05	0.000374	CcSEcCtD
Fluvoxamine—Pain—Etoposide—uterine cancer	9.44e-05	0.000374	CcSEcCtD
Fluvoxamine—Constipation—Etoposide—uterine cancer	9.44e-05	0.000374	CcSEcCtD
Fluvoxamine—Conjunctivitis—Epirubicin—uterine cancer	9.43e-05	0.000373	CcSEcCtD
Fluvoxamine—Urinary tract infection—Epirubicin—uterine cancer	9.43e-05	0.000373	CcSEcCtD
Fluvoxamine—Dysuria—Doxorubicin—uterine cancer	9.41e-05	0.000373	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—uterine cancer	9.35e-05	0.00037	CcSEcCtD
Fluvoxamine—Sweating—Epirubicin—uterine cancer	9.3e-05	0.000368	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—uterine cancer	9.3e-05	0.000368	CcSEcCtD
Fluvoxamine—Haematuria—Epirubicin—uterine cancer	9.25e-05	0.000366	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—uterine cancer	9.19e-05	0.000364	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Epirubicin—uterine cancer	9.17e-05	0.000363	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—uterine cancer	9.16e-05	0.000363	CcSEcCtD
Fluvoxamine—Epistaxis—Epirubicin—uterine cancer	9.15e-05	0.000362	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—uterine cancer	9.11e-05	0.000361	CcSEcCtD
Fluvoxamine—Sinusitis—Epirubicin—uterine cancer	9.1e-05	0.00036	CcSEcCtD
Fluvoxamine—Feeling abnormal—Etoposide—uterine cancer	9.09e-05	0.00036	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—uterine cancer	9.08e-05	0.000359	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—uterine cancer	9.06e-05	0.000359	CcSEcCtD
Fluvoxamine—Agranulocytosis—Epirubicin—uterine cancer	9.05e-05	0.000358	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—uterine cancer	9.03e-05	0.000357	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Etoposide—uterine cancer	9.02e-05	0.000357	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—uterine cancer	8.97e-05	0.000355	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	8.9e-05	0.000352	CcSEcCtD
Fluvoxamine—Bradycardia—Epirubicin—uterine cancer	8.86e-05	0.000351	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—uterine cancer	8.82e-05	0.000349	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—uterine cancer	8.8e-05	0.000348	CcSEcCtD
Fluvoxamine—Urticaria—Etoposide—uterine cancer	8.77e-05	0.000347	CcSEcCtD
Fluvoxamine—Haemoglobin—Epirubicin—uterine cancer	8.75e-05	0.000346	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—uterine cancer	8.75e-05	0.000346	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—uterine cancer	8.75e-05	0.000346	CcSEcCtD
Fluvoxamine—Rhinitis—Epirubicin—uterine cancer	8.73e-05	0.000346	CcSEcCtD
Fluvoxamine—Abdominal pain—Etoposide—uterine cancer	8.72e-05	0.000345	CcSEcCtD
Fluvoxamine—Body temperature increased—Etoposide—uterine cancer	8.72e-05	0.000345	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—uterine cancer	8.72e-05	0.000345	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—uterine cancer	8.72e-05	0.000345	CcSEcCtD
Fluvoxamine—Hepatitis—Epirubicin—uterine cancer	8.71e-05	0.000345	CcSEcCtD
Fluvoxamine—Haemorrhage—Epirubicin—uterine cancer	8.71e-05	0.000345	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Epirubicin—uterine cancer	8.66e-05	0.000343	CcSEcCtD
Fluvoxamine—Pharyngitis—Epirubicin—uterine cancer	8.64e-05	0.000342	CcSEcCtD
Fluvoxamine—ABCB1—female gonad—uterine cancer	8.62e-05	0.00907	CbGeAlD
Fluvoxamine—Sweating—Doxorubicin—uterine cancer	8.6e-05	0.000341	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Epirubicin—uterine cancer	8.6e-05	0.00034	CcSEcCtD
Fluvoxamine—Oedema peripheral—Epirubicin—uterine cancer	8.58e-05	0.00034	CcSEcCtD
Fluvoxamine—ABCB1—vagina—uterine cancer	8.56e-05	0.00902	CbGeAlD
Fluvoxamine—Haematuria—Doxorubicin—uterine cancer	8.56e-05	0.000339	CcSEcCtD
Fluvoxamine—Urethral disorder—Epirubicin—uterine cancer	8.54e-05	0.000338	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—uterine cancer	8.49e-05	0.000336	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—uterine cancer	8.47e-05	0.000335	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—uterine cancer	8.42e-05	0.000333	CcSEcCtD
Fluvoxamine—Visual impairment—Epirubicin—uterine cancer	8.39e-05	0.000332	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—uterine cancer	8.38e-05	0.000332	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—uterine cancer	8.23e-05	0.000326	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—uterine cancer	8.2e-05	0.000325	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—uterine cancer	8.14e-05	0.000322	CcSEcCtD
Fluvoxamine—Hypersensitivity—Etoposide—uterine cancer	8.13e-05	0.000322	CcSEcCtD
Fluvoxamine—Tinnitus—Epirubicin—uterine cancer	8.12e-05	0.000321	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—uterine cancer	8.1e-05	0.000321	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—uterine cancer	8.08e-05	0.00032	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—uterine cancer	8.08e-05	0.00032	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—uterine cancer	8.06e-05	0.000319	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—uterine cancer	8.06e-05	0.000319	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—uterine cancer	8.02e-05	0.000317	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—uterine cancer	8e-05	0.000317	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—uterine cancer	7.96e-05	0.000315	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—uterine cancer	7.94e-05	0.000314	CcSEcCtD
Fluvoxamine—Asthenia—Etoposide—uterine cancer	7.92e-05	0.000313	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—uterine cancer	7.9e-05	0.000313	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—uterine cancer	7.9e-05	0.000313	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—uterine cancer	7.81e-05	0.000309	CcSEcCtD
Fluvoxamine—Pruritus—Etoposide—uterine cancer	7.81e-05	0.000309	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—uterine cancer	7.78e-05	0.000308	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—uterine cancer	7.76e-05	0.000307	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—uterine cancer	7.69e-05	0.000305	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—uterine cancer	7.63e-05	0.000302	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—uterine cancer	7.62e-05	0.000302	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—uterine cancer	7.58e-05	0.0003	CcSEcCtD
Fluvoxamine—Diarrhoea—Etoposide—uterine cancer	7.55e-05	0.000299	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—uterine cancer	7.53e-05	0.000298	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—uterine cancer	7.51e-05	0.000297	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—uterine cancer	7.48e-05	0.000296	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—uterine cancer	7.47e-05	0.000296	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—uterine cancer	7.44e-05	0.000294	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—uterine cancer	7.42e-05	0.000294	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—uterine cancer	7.36e-05	0.000291	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—uterine cancer	7.33e-05	0.00029	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—uterine cancer	7.31e-05	0.000289	CcSEcCtD
Fluvoxamine—Dizziness—Etoposide—uterine cancer	7.3e-05	0.000289	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—uterine cancer	7.29e-05	0.000289	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—uterine cancer	7.23e-05	0.000286	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—uterine cancer	7.2e-05	0.000285	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—uterine cancer	7.14e-05	0.000283	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—uterine cancer	7.12e-05	0.000282	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—uterine cancer	7.06e-05	0.000279	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—uterine cancer	7.03e-05	0.000278	CcSEcCtD
Fluvoxamine—Vomiting—Etoposide—uterine cancer	7.02e-05	0.000278	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—uterine cancer	7.01e-05	0.000278	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—uterine cancer	7.01e-05	0.000277	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—uterine cancer	6.97e-05	0.000276	CcSEcCtD
Fluvoxamine—Rash—Etoposide—uterine cancer	6.96e-05	0.000275	CcSEcCtD
Fluvoxamine—Dermatitis—Etoposide—uterine cancer	6.95e-05	0.000275	CcSEcCtD
Fluvoxamine—Headache—Etoposide—uterine cancer	6.91e-05	0.000274	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—uterine cancer	6.91e-05	0.000274	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—uterine cancer	6.88e-05	0.000272	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—uterine cancer	6.87e-05	0.000272	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—uterine cancer	6.84e-05	0.000271	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—uterine cancer	6.81e-05	0.00027	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—uterine cancer	6.81e-05	0.00027	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—uterine cancer	6.8e-05	0.000269	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—uterine cancer	6.78e-05	0.000269	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—uterine cancer	6.78e-05	0.000269	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—uterine cancer	6.74e-05	0.000267	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—uterine cancer	6.7e-05	0.000265	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—uterine cancer	6.66e-05	0.000264	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—uterine cancer	6.61e-05	0.000262	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—uterine cancer	6.61e-05	0.000262	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—uterine cancer	6.57e-05	0.00026	CcSEcCtD
Fluvoxamine—Nausea—Etoposide—uterine cancer	6.56e-05	0.00026	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—uterine cancer	6.54e-05	0.000259	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—uterine cancer	6.51e-05	0.000258	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—uterine cancer	6.48e-05	0.000257	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—uterine cancer	6.45e-05	0.000255	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—uterine cancer	6.45e-05	0.000255	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—uterine cancer	6.45e-05	0.000255	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—uterine cancer	6.45e-05	0.000255	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—uterine cancer	6.43e-05	0.000255	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—uterine cancer	6.38e-05	0.000252	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—uterine cancer	6.32e-05	0.00025	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—uterine cancer	6.31e-05	0.00025	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—uterine cancer	6.3e-05	0.000249	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—uterine cancer	6.29e-05	0.000249	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—uterine cancer	6.28e-05	0.000249	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—uterine cancer	6.24e-05	0.000247	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—uterine cancer	6.2e-05	0.000245	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—uterine cancer	6.19e-05	0.000245	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—uterine cancer	6.19e-05	0.000245	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—uterine cancer	6.16e-05	0.000244	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—uterine cancer	6.15e-05	0.000243	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—uterine cancer	6.12e-05	0.000242	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—uterine cancer	6.09e-05	0.000241	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—uterine cancer	6.08e-05	0.000241	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—uterine cancer	6.07e-05	0.00024	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—uterine cancer	6.06e-05	0.00024	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—uterine cancer	6.06e-05	0.00024	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—uterine cancer	6.04e-05	0.000239	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—uterine cancer	5.98e-05	0.000237	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—uterine cancer	5.97e-05	0.000236	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—uterine cancer	5.97e-05	0.000236	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—uterine cancer	5.97e-05	0.000236	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—uterine cancer	5.95e-05	0.000236	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—uterine cancer	5.9e-05	0.000234	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—uterine cancer	5.9e-05	0.000233	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—uterine cancer	5.84e-05	0.000231	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—uterine cancer	5.78e-05	0.000229	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—uterine cancer	5.77e-05	0.000229	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—uterine cancer	5.72e-05	0.000227	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—uterine cancer	5.72e-05	0.000227	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—uterine cancer	5.69e-05	0.000225	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.64e-05	0.000223	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—uterine cancer	5.63e-05	0.000223	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—uterine cancer	5.61e-05	0.000222	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—uterine cancer	5.6e-05	0.000222	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—uterine cancer	5.6e-05	0.000222	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—uterine cancer	5.59e-05	0.000221	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—uterine cancer	5.55e-05	0.00022	CcSEcCtD
Fluvoxamine—ABCB1—lymph node—uterine cancer	5.54e-05	0.00583	CbGeAlD
Fluvoxamine—Hyperhidrosis—Doxorubicin—uterine cancer	5.53e-05	0.000219	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—uterine cancer	5.52e-05	0.000218	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—uterine cancer	5.5e-05	0.000218	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—uterine cancer	5.46e-05	0.000216	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—uterine cancer	5.45e-05	0.000216	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—uterine cancer	5.38e-05	0.000213	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—uterine cancer	5.35e-05	0.000212	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—uterine cancer	5.34e-05	0.000211	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—uterine cancer	5.33e-05	0.000211	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—uterine cancer	5.29e-05	0.000209	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—uterine cancer	5.29e-05	0.000209	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.21e-05	0.000206	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—uterine cancer	5.18e-05	0.000205	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—uterine cancer	5.14e-05	0.000203	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—uterine cancer	5.1e-05	0.000202	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—uterine cancer	5.1e-05	0.000202	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—uterine cancer	5.09e-05	0.000201	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—uterine cancer	5.06e-05	0.0002	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—uterine cancer	5.04e-05	0.000199	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—uterine cancer	4.98e-05	0.000197	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.94e-05	0.000196	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—uterine cancer	4.93e-05	0.000195	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—uterine cancer	4.91e-05	0.000195	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—uterine cancer	4.89e-05	0.000194	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—uterine cancer	4.89e-05	0.000194	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—uterine cancer	4.89e-05	0.000194	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—uterine cancer	4.89e-05	0.000194	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—uterine cancer	4.72e-05	0.000187	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—uterine cancer	4.68e-05	0.000185	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—uterine cancer	4.56e-05	0.00018	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—uterine cancer	4.55e-05	0.00018	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—uterine cancer	4.52e-05	0.000179	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—uterine cancer	4.52e-05	0.000179	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—uterine cancer	4.44e-05	0.000176	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—uterine cancer	4.38e-05	0.000173	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—uterine cancer	4.23e-05	0.000168	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—uterine cancer	4.22e-05	0.000167	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—uterine cancer	4.11e-05	0.000163	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—uterine cancer	4.09e-05	0.000162	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—uterine cancer	4.05e-05	0.00016	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—uterine cancer	3.93e-05	0.000156	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—uterine cancer	3.92e-05	0.000155	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—uterine cancer	3.9e-05	0.000154	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—uterine cancer	3.9e-05	0.000154	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—uterine cancer	3.88e-05	0.000153	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—uterine cancer	3.79e-05	0.00015	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—uterine cancer	3.67e-05	0.000145	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—uterine cancer	3.64e-05	0.000144	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—uterine cancer	3.61e-05	0.000143	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—uterine cancer	3.61e-05	0.000143	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—uterine cancer	3.59e-05	0.000142	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—uterine cancer	3.4e-05	0.000135	CcSEcCtD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.81e-05	0.00129	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.8e-05	0.00128	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.74e-05	0.00125	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.71e-05	0.00124	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.7e-05	0.00124	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.7e-05	0.00124	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.67e-05	0.00122	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.67e-05	0.00122	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.66e-05	0.00122	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.62e-05	0.0012	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.61e-05	0.0012	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.58e-05	0.00118	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.55e-05	0.00117	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.41e-05	0.0011	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.38e-05	0.00109	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.38e-05	0.00109	CbGpPWpGaD
Fluvoxamine—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—STAR—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKR1B1—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SRD5A2—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NDUFB11—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.3e-05	0.00105	CbGpPWpGaD
Fluvoxamine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	2.29e-05	0.00105	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.28e-05	0.00104	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.28e-05	0.00104	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NDUFB11—uterine cancer	2.2e-05	0.00101	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SRD5A2—uterine cancer	2.2e-05	0.00101	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TP53—uterine cancer	2.18e-05	0.000997	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.15e-05	0.000983	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.14e-05	0.000979	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.05e-05	0.000938	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.02e-05	0.000925	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.02e-05	0.000923	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.01e-05	0.00092	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.99e-05	0.000911	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.96e-05	0.000896	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—POLD1—uterine cancer	1.83e-05	0.000838	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.8e-05	0.000825	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.8e-05	0.000825	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NDUFB11—uterine cancer	1.76e-05	0.000805	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SRD5A2—uterine cancer	1.76e-05	0.000805	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.75e-05	0.000801	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—STAR—uterine cancer	1.72e-05	0.000789	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.000789	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.71e-05	0.000783	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.7e-05	0.000777	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—STAR—uterine cancer	1.69e-05	0.000773	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.69e-05	0.000773	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—STAR—uterine cancer	1.68e-05	0.000772	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.68e-05	0.000772	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.67e-05	0.000766	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.66e-05	0.000759	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.66e-05	0.000759	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.65e-05	0.000757	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.64e-05	0.000752	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.64e-05	0.000752	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.6e-05	0.000731	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—HRAS—uterine cancer	1.59e-05	0.000729	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—STAR—uterine cancer	1.59e-05	0.000729	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKR1B1—uterine cancer	1.59e-05	0.000729	CbGpPWpGaD
Fluvoxamine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	1.57e-05	0.000721	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.57e-05	0.00072	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—RRM2—uterine cancer	1.52e-05	0.000698	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.51e-05	0.00069	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—DCN—uterine cancer	1.48e-05	0.000678	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.47e-05	0.000676	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.4e-05	0.000643	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.4e-05	0.000643	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.39e-05	0.000639	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.37e-05	0.000626	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.36e-05	0.000624	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POLD1—uterine cancer	1.35e-05	0.000619	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POLD1—uterine cancer	1.32e-05	0.000607	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POLD1—uterine cancer	1.32e-05	0.000605	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.32e-05	0.000603	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.3e-05	0.000596	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—STAR—uterine cancer	1.3e-05	0.000596	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.29e-05	0.000591	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.29e-05	0.00059	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.29e-05	0.00059	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.27e-05	0.000582	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—STAR—uterine cancer	1.27e-05	0.000582	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.000579	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.26e-05	0.000576	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POLD1—uterine cancer	1.25e-05	0.000572	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.24e-05	0.000567	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.24e-05	0.000566	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—HRAS—uterine cancer	1.22e-05	0.000559	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.2e-05	0.000549	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.2e-05	0.000549	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—STAR—uterine cancer	1.2e-05	0.000549	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.19e-05	0.000544	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—STAR—uterine cancer	1.19e-05	0.000544	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.17e-05	0.000538	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.17e-05	0.000535	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.14e-05	0.00052	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—RRM2—uterine cancer	1.13e-05	0.000516	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—RRM2—uterine cancer	1.1e-05	0.000506	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—RRM2—uterine cancer	1.1e-05	0.000505	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—DCN—uterine cancer	1.09e-05	0.000501	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.08e-05	0.000496	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.08e-05	0.000496	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—DCN—uterine cancer	1.07e-05	0.000491	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—DCN—uterine cancer	1.07e-05	0.00049	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—RRM2—uterine cancer	1.04e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000472	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—STK11—uterine cancer	1.03e-05	0.00047	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.03e-05	0.00047	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POLD1—uterine cancer	1.02e-05	0.000468	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.01e-05	0.000465	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—STAR—uterine cancer	1.01e-05	0.000465	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—DCN—uterine cancer	1.01e-05	0.000463	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000463	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000462	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1e-05	0.000459	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POLD1—uterine cancer	9.97e-06	0.000457	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKR1C3—uterine cancer	9.74e-06	0.000446	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.66e-06	0.000442	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.56e-06	0.000438	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKR1C3—uterine cancer	9.54e-06	0.000437	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP11A1—uterine cancer	9.52e-06	0.000436	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKR1C3—uterine cancer	9.52e-06	0.000436	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POLD1—uterine cancer	9.4e-06	0.00043	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKR1C1—uterine cancer	9.33e-06	0.000427	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POLD1—uterine cancer	9.32e-06	0.000427	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKR1C3—uterine cancer	8.99e-06	0.000412	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.87e-06	0.000406	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKR1C1—uterine cancer	8.79e-06	0.000403	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKR1C1—uterine cancer	8.71e-06	0.000399	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.58e-06	0.000393	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—RRM2—uterine cancer	8.52e-06	0.00039	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—RRM2—uterine cancer	8.31e-06	0.000381	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—DCN—uterine cancer	8.27e-06	0.000379	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—DCN—uterine cancer	8.07e-06	0.00037	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POLD1—uterine cancer	7.96e-06	0.000365	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—RRM2—uterine cancer	7.83e-06	0.000359	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—STAR—uterine cancer	7.83e-06	0.000359	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.83e-06	0.000359	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.79e-06	0.000357	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—RRM2—uterine cancer	7.77e-06	0.000356	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—uterine cancer	7.71e-06	0.000353	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—DCN—uterine cancer	7.61e-06	0.000348	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP11A1—uterine cancer	7.6e-06	0.000348	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP19A1—uterine cancer	7.59e-06	0.000347	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—STK11—uterine cancer	7.59e-06	0.000347	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—DCN—uterine cancer	7.54e-06	0.000345	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.45e-06	0.000341	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—STK11—uterine cancer	7.43e-06	0.00034	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP19A1—uterine cancer	7.43e-06	0.00034	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP19A1—uterine cancer	7.41e-06	0.00034	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—STK11—uterine cancer	7.41e-06	0.00034	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.36e-06	0.000337	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.25e-06	0.000332	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKR1C3—uterine cancer	7.18e-06	0.000329	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.17e-06	0.000328	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.1e-06	0.000325	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—STK11—uterine cancer	7e-06	0.000321	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP19A1—uterine cancer	7e-06	0.000321	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKR1C3—uterine cancer	6.77e-06	0.00031	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKR1C3—uterine cancer	6.71e-06	0.000307	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—RRM2—uterine cancer	6.64e-06	0.000304	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.58e-06	0.000301	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—DCN—uterine cancer	6.44e-06	0.000295	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.27e-06	0.000287	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POLD1—uterine cancer	6.14e-06	0.000281	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.07e-06	0.000278	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.75e-06	0.000263	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.73e-06	0.000263	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—STK11—uterine cancer	5.73e-06	0.000263	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.73e-06	0.000263	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—uterine cancer	5.7e-06	0.000261	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP19A1—uterine cancer	5.59e-06	0.000256	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—STK11—uterine cancer	5.59e-06	0.000256	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—uterine cancer	5.58e-06	0.000256	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—uterine cancer	5.57e-06	0.000255	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.38e-06	0.000246	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.27e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—STK11—uterine cancer	5.27e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—uterine cancer	5.26e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.23e-06	0.000239	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—STK11—uterine cancer	5.23e-06	0.000239	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.13e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—RRM2—uterine cancer	5.12e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DCN—uterine cancer	4.97e-06	0.000228	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.91e-06	0.000225	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.68e-06	0.000215	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.68e-06	0.000214	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.64e-06	0.000212	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—STK11—uterine cancer	4.47e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.47e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.42e-06	0.000203	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—uterine cancer	4.31e-06	0.000197	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—uterine cancer	4.29e-06	0.000196	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—uterine cancer	4.2e-06	0.000193	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.19e-06	0.000192	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—EP300—uterine cancer	4.09e-06	0.000187	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—uterine cancer	3.96e-06	0.000181	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—uterine cancer	3.93e-06	0.00018	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.8e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.46e-06	0.000159	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—STK11—uterine cancer	3.45e-06	0.000158	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.45e-06	0.000158	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—uterine cancer	3.36e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—uterine cancer	3.17e-06	0.000145	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—uterine cancer	3.11e-06	0.000142	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—uterine cancer	3.1e-06	0.000142	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.02e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—EP300—uterine cancer	3.02e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—EP300—uterine cancer	2.96e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.96e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—EP300—uterine cancer	2.96e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—uterine cancer	2.93e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—EP300—uterine cancer	2.79e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.59e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—uterine cancer	2.47e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—uterine cancer	2.4e-06	0.00011	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—uterine cancer	2.34e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—EP300—uterine cancer	2.29e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.24e-06	0.000102	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—EP300—uterine cancer	2.23e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—uterine cancer	2.2e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.19e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.19e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—uterine cancer	2.18e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—EP300—uterine cancer	2.1e-06	9.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—EP300—uterine cancer	2.08e-06	9.54e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—uterine cancer	2.07e-06	9.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—uterine cancer	1.87e-06	8.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—uterine cancer	1.83e-06	8.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—uterine cancer	1.79e-06	8.2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—uterine cancer	1.79e-06	8.18e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—EP300—uterine cancer	1.78e-06	8.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.69e-06	7.74e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—uterine cancer	1.69e-06	7.73e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.65e-06	7.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.55e-06	7.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.54e-06	7.06e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—uterine cancer	1.44e-06	6.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—uterine cancer	1.38e-06	6.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—EP300—uterine cancer	1.37e-06	6.29e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—uterine cancer	1.35e-06	6.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.32e-06	6.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—uterine cancer	1.27e-06	5.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—uterine cancer	1.26e-06	5.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—uterine cancer	1.08e-06	4.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.02e-06	4.66e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—uterine cancer	8.3e-07	3.8e-05	CbGpPWpGaD
